Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitis.

de Oliveira CP, Stefano JT, de Siqueira ER, Silva LS, de Campos Mazo DF, Lima VM, Furuya CK, Mello ES, Souza FG, Rabello F, Santos TE, Nogueira MA, Caldwell SH, Alves VA, Carrilho FJ.

Hepatol Res. 2008;38(2):159-65. doi: 10.1111/j.1872-034X.2007.00215.x.

PMID:
18197877
[PubMed]
2.

One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study.

Huang MA, Greenson JK, Chao C, Anderson L, Peterman D, Jacobson J, Emick D, Lok AS, Conjeevaram HS.

Am J Gastroenterol. 2005 May;100(5):1072-81.

PMID:
15842581
[PubMed - indexed for MEDLINE]
3.

Effects of vitamin E treatment on peroxisome proliferator-activated receptor-alpha expression and insulin resistance in patients with non-alcoholic steatohepatitis: results of a pilot study.

Yakaryilmaz F, Guliter S, Savas B, Erdem O, Ersoy R, Erden E, Akyol G, Bozkaya H, Ozenirler S.

Intern Med J. 2007 Apr;37(4):229-35.

PMID:
17388862
[PubMed - indexed for MEDLINE]
4.

Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse.

Sterling RK, Smith PG, Brunt EM.

J Clin Gastroenterol. 2013 Feb;47(2):182-7. doi: 10.1097/MCG.0b013e318264181d.

PMID:
23059409
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Effect of a Probiotic and Metformin on Liver Aminotransferases in Non-alcoholic Steatohepatitis: A Double Blind Randomized Clinical Trial.

Shavakhi A, Minakari M, Firouzian H, Assali R, Hekmatdoost A, Ferns G.

Int J Prev Med. 2013 May;4(5):531-7.

PMID:
23930163
[PubMed]
Free PMC Article
6.

Non-alcoholic steatohepatitis in children.

Nanda K.

Pediatr Transplant. 2004 Dec;8(6):613-8. Review.

PMID:
15598336
[PubMed - indexed for MEDLINE]
7.

Effects of lifestyle changes including specific dietary intervention and physical activity in the management of patients with chronic hepatitis C--a randomized trial.

Rusu E, Jinga M, Enache G, Rusu F, Dragomir AD, Ancuta I, Draguţ R, Parpala C, Nan R, Sima I, Ateia S, Stoica V, Cheţa DM, Radulian G.

Nutr J. 2013 Aug 14;12:119. doi: 10.1186/1475-2891-12-119.

PMID:
23941362
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Fatty liver disease: predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity.

Liew PL, Lee WJ, Wang W, Lee YC, Chen WY, Fang CL, Huang MT.

Obes Surg. 2008 Jul;18(7):847-53. doi: 10.1007/s11695-007-9355-0. Epub 2008 May 6.

PMID:
18459024
[PubMed - indexed for MEDLINE]
9.

Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: An open-label, pilot study.

Yoneda M, Fujita K, Nozaki Y, Endo H, Takahashi H, Hosono K, Suzuki K, Mawatari H, Kirikoshi H, Inamori M, Saito S, Iwasaki T, Terauchi Y, Kubota K, Maeyama S, Nakajima A.

Hepatol Res. 2010 Jun;40(6):566-73. doi: 10.1111/j.1872-034X.2010.00644.x. Epub 2010 Apr 14.

PMID:
20412324
[PubMed]
10.

Irisin in patients with nonalcoholic fatty liver disease.

Polyzos SA, Kountouras J, Anastasilakis AD, Geladari EV, Mantzoros CS.

Metabolism. 2014 Feb;63(2):207-17. doi: 10.1016/j.metabol.2013.09.013. Epub 2013 Oct 18.

PMID:
24140091
[PubMed - indexed for MEDLINE]
11.

Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis.

Manco M, Marcellini M, Devito R, Comparcola D, Sartorelli MR, Nobili V.

Int J Obes (Lond). 2008 Feb;32(2):381-7. Epub 2007 Dec 18.

PMID:
18087267
[PubMed - indexed for MEDLINE]
12.

Anthropometric and biochemical characteristics of patients with nonalcoholic fatty liver diagnosed by non-invasive diagnostic methods.

Novakovic T, Mekic M, Smilic L, Smilic T, Inić-Kostic B, Jovicevic L, Mirkovic Z, Milinic S.

Med Arch. 2014;68(1):22-6.

PMID:
24783906
[PubMed - indexed for MEDLINE]
13.

Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study.

Laurin J, Lindor KD, Crippin JS, Gossard A, Gores GJ, Ludwig J, Rakela J, McGill DB.

Hepatology. 1996 Jun;23(6):1464-7.

PMID:
8675165
[PubMed - indexed for MEDLINE]
14.

Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.

Nobili V, Manco M, Ciampalini P, Alisi A, Devito R, Bugianesi E, Marcellini M, Marchesini G.

Clin Ther. 2008 Jun;30(6):1168-76. doi: 10.1016/j.clinthera.2008.06.012.

PMID:
18640473
[PubMed - indexed for MEDLINE]
15.

A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver.

Pais R, Charlotte F, Fedchuk L, Bedossa P, Lebray P, Poynard T, Ratziu V; LIDO Study Group.

J Hepatol. 2013 Sep;59(3):550-6. doi: 10.1016/j.jhep.2013.04.027. Epub 2013 May 9.

PMID:
23665288
[PubMed - indexed for MEDLINE]
16.

Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.

Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC.

Obes Surg. 2006 Dec;16(12):1584-93.

PMID:
17217634
[PubMed - indexed for MEDLINE]
17.

Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study.

Hasegawa T, Yoneda M, Nakamura K, Makino I, Terano A.

Aliment Pharmacol Ther. 2001 Oct;15(10):1667-72.

PMID:
11564008
[PubMed - indexed for MEDLINE]
Free Article
18.

A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease.

Fernández-Miranda C, Pérez-Carreras M, Colina F, López-Alonso G, Vargas C, Solís-Herruzo JA.

Dig Liver Dis. 2008 Mar;40(3):200-5. doi: 10.1016/j.dld.2007.10.002.

PMID:
18261709
[PubMed - indexed for MEDLINE]
19.

Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.

Eslami L, Merat S, Malekzadeh R, Nasseri-Moghaddam S, Aramin H.

Cochrane Database Syst Rev. 2013 Dec 27;12:CD008623. doi: 10.1002/14651858.CD008623.pub2. Review.

PMID:
24374462
[PubMed - indexed for MEDLINE]
20.

Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study.

Georgescu EF, Georgescu M.

J Gastrointestin Liver Dis. 2007 Mar;16(1):39-46.

PMID:
17410287
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk